Pharma and Biotech Research News New York

Pharma, Biopharma & Biotech News

Sep 23

Virpax selects Altasciences to develop a drug to prevent the spread of flu like viruses

AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza...

Sep 15

Aclipse Therapeutics Expands Drug Development Pipeline for Gastroparesis

Aclipse Therapeutics is an innovative biopharmaceutical company developing life-changing treatments for patients with severe diseases.

Sep 13

Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX

These data play an important role in the development of KP1077 as we address the unmet needs of people living with rare sleep disorders

Sep 12

Shine Technologies and Curadh MTR Expand Partnership for Cancer Therapies using Terbium and Lutetium

Curadh intends to focus its beta development with this novel isotope in molecularly targeted therapies for solid tumors.

Aug 28

Inhibikase Therapeutics develops novel formulation of risvodetinib

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease...

Aug 25

Botanical Solution raises an additional $7 Million to scale up production of vaccine adjuvants

Botanical Solution has a proprietary platform for sustainable and improved production of high quality Advanced Botanical Materials (ABMs)

Aug 18

Novo Holdings participates in $290 million strategic financing of Sangon Biotech

Shanghai Sangon Biotech is a provider with comprehensive portfolio coverage in the life sciences research product and service industries

Aug 7

AI-driven pioneer in drug formulation, Persist AI, raises $4 million

Persist AI specializes in building and optimizing long-acting injectable formulations

Aug 4

Adamis Pharmaceuticals prices $8 million public offering

Adamis’ commercial products approved by the FDA include ZIMHI® (naloxone) Injection for the treatment of opioid overdose,

Jul 24

PainReform, a clinical-stage specialty pharmaceutical company prices $2.7 million financing

PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure

Jul 19

Clinical stage biopharmaceutical company Galmed Pharmaceuticals prices $7 million public offering

Galmed Pharmaceuticals has focused almost exclusively on developing Aramchol for the treatment of NASH.

Jun 26

Tagworks Pharmaceuticals closes a $65 Million financing to advance its Click-to-Release therapeutics

Tagworks Pharmaceuticals, pioneer of the Click-to-Release approach, is a precision therapy company.

Jun 21

Turbine, which uses cell simulations increases its current financing to €25.5 million

Turbine's vision is to overcome the limitations in identifying oncology treatments with patient benefit by combining molecular biology...

Jun 19

RK Pharma wraps up acquisition of developer of clinical critical therapies VGYAAN Pharmaceuticals

RK Pharma focuses on the development, manufacturing, and sale of high quality and affordable generic pharmaceutical products worldwide.

Jun 13

HanAll Biopharma and Daewoong Pharmaceutical invest in Vincere Biosciences for Parkinson's Research

This partnership highlights the joining of forces across a shared mission to deliver disease-modifying medicines for Parkinson's disease.

Jun 7

CERo Therapeutics to merge with SPAC and advance engineered T Cell therapeutics

Phoenix Biotech Acquisition Corp. (NASDAQ: PBAX) is a blank-check company formed for the purpose of effecting a merger, share exchange...

Jun 2

Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure

Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.

May 26

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons

. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...

May 19

Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

May 12

Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction

Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate

May 11

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

May 6

MultiOmic Health Closes $6.2 Million for precision medicines for metabolic syndrome conditions

The proceeds of this financing will be used to demonstrate proof-of-concept for MultiOmic’s MOHSAIC platform in diabetic kidney disease

May 5

Galmed Pharmaceuticals and OnKai partner for clinical studies in underserved communities

Through this partnership, the companies intend to facilitate faster clinical trial enrollment and provide patients with access to medicines

May 3

Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials

We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum

Apr 25

ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP

ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,

Apr 18

Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases

Apr 14

Novo Holdings participates in $105 million funding in Alentis Therapeutics

Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.

Apr 3

Orion is building a pharmaceutical research ecosystem using data and artificial intelligence

Artificial intelligence-guided use of data is a competitive advantage when developing new innovative medicines.

Mar 30

Viking Therapeutics prices $250 Million public common stock offering

Viking Therapeutics is a clinical-stage biopharmaceutical company that is developing novel first-in-class or best-in-class therapies

Mar 28

EpiBiologics raises $50 million for next-generation antibody-based protein degradation platform

EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins.

Mar 4

Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer

Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.

Mar 2

Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

RADICAVA is administered in 28-day cycles by IV infusion for ALS.

Feb 24

Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million

. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...

Feb 22

Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products

Feb 17

LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs

The funds will be used for the development of novel biologics targeting ion channels and G-procoupled receptors

Feb 15

Great Product Ventures initiates strategic relationship with life sciences regulatory services firm

Great Product Ventures is a venture development firm whose mission is to identify the top European Companies to commercialize and fund...

Feb 14

Nasdaq-listed SeqLL prices $1.8 million offering

The gross proceeds to the Company from the Offering are estimated to be approximately $1.8 million.

Feb 13

Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services

Feb 1

Panbela prices $15 million public offering

CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...

Jan 18

To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab

The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.

Jan 10

Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health

imaware’s mission is to empower the health of humanity by providing testing and technology solutions for healing at scale.

Jan 7

Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics

AMD is the leading cause of blindness in people 55 and older, affecting more than 150 million people worldwide and 10 million people in US

Jan 4

Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

Enrollment for the clinical trials is expected to begin in the second quarter of 2023

Jan 3

Biocytogen and Hansoh Pharma Enter Into An Antibody License Agreement

Project Integrum is a large-scale antibody drug development project for 1000+ potential drug targets

Dec 27, 2022

Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies

Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze...

Dec 11, 2022

iBio, an AI-driven innovator of precision antibody immunotherapies, closes $3.5 million financing

iBio’s mission is to decrease drug failures, shorten drug development timelines, and open up new frontiers against the most promising...

Dec 9, 2022

OMNY Health Closes $17 Million to Lead the Next Generation of Real-World Data-Driven Decision-Making

sahi Kasei, is publicly calling for new proposals for drug development research as part of its efforts for open innovation to promote..

Nov 29, 2022

MIT: New CRISPR-based tool inserts large DNA sequences at desired sites in cells

The researchers are now further exploring the possibility of using this tool as a possible way to replace the defective cystic fibrosis gene

Nov 23, 2022

scPharmaceuticals Announces Pricing of $50 Million Public Offering

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...

Nov 5, 2022

H.I.G. Capital acquires leading global clinical research organization Celerion

Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic